RD Johnston, S., Kilburn, L. S., Ellis, P., Dodwell, D., Cameron, D., Hayward, L., Im, Y.-H., Braybrooke, J. P., Brunt, A. M., Cheung, K.-L., Jyothirmayi, R., Robinson, A., Wardley, A. M., Wheatley, D., Howell, A., Coombes, G., Sergenson, N., Sin, H.-J., Folkerd, E., Dowsett, M., …investigators, S. (2013). Fulvestrant plus anastrozole or placebo versus exemestane alone after progression on non-steroidal aromatase inhibitors in postmenopausal patients with hormone-receptor-positive locally advanced or metastatic breast cancer (SoFEA): a composite, multicentre, phase 3 randomised trial. LANCET ONCOLOGY, 14(10), 989-998. https://doi.org/10.1016/S1470-2045%2813%2970322-X